Search results
Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals
Zacks· 1 day agoIntra-Cellular Therapies (ITCI Quick QuoteITCI - Free Report) announced positive top-line results...
Impact of cognitive impairment on driving behaviour and route choices of older drivers: a real-world...
Nature· 1 day agoThe study comprised 246 participants, all of whom were 65 years of age or older, required to drive at least once a week at baseline, have a valid driver’s license, drive a ...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance· 2 days agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...
Fact check: A study put England fourth in the world for primary school reading
Press Association News via AOL· 2 days agoConservative minister Mark Harper said in an interview on Sky News that primary school children in...
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
Zacks via Yahoo Finance· 2 days agoWhile the SKYLINE study narrowly missed out on its primary endpoint of reducing convulsive seizure...
Big tech brands selling customers short on security – Which?
PA Media: Money via Yahoo Finance· 8 hours agoOn smart speakers, Belkin and Audio Pro were silent on support policies, the watchdog reported. And...
Hern wins Oklahoma GOP congressional primary after lopsided funding battle
Fox News via Yahoo News· 1 day agoHern won the Republican primary for Oklahoma's First Congressional District and will face off with...
Prevent low back pain with this simple lifestyle change
CNN via Yahoo News· 9 hours agoState University in Winston-Salem, North Carolina. She was not involved in the study. “This is...
New fathers should be screened for postpartum depression too, study says
Rapid City Journal· 1 day agoMen are far from immune to the emotional strain of becoming a new parent, and the study comes amid a...
Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People...
Morningstar· 5 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma – The ...